Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.34 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | INMT | O95050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7154976 | 1.00 | FFAR3 (0.34) | FFAR3DPP4INMT | |
| SCHEMBL14640008 | 0.86 | ALDH1A1 (0.33) | DPP4 | |
| SCHEMBL9649192 | 0.85 | BDKRB2 (0.35) | FFAR3 | |
| SCHEMBL28537405 | 0.82 | DPP4 (0.34) | DPP4 | |
| SCHEMBL25347423 | 0.79 | NPSR1 (0.35) | DPP4 | |
| SCHEMBL25726382 | 0.79 | CYP3A4 (0.33) | DPP4 | |
| SCHEMBL21618645 | 0.79 | HSD11B1 (0.37) | FFAR3 | |
| SCHEMBL25347426 | 0.79 | NPSR1 (0.35) | DPP4 | |
| SCHEMBL21382759 | 0.79 | INMT (0.32) | FFAR3DPP4INMT | |
| SCHEMBL15920931 | 0.79 | S1PR1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021093817-A1 | IMMUNOMODULATORY COMPOUNDS, COMPOSITION AND APPLICATION THEREOF | 杭州和正医药有限公司 | 2021-05-20 | — | — | WO | disclosed |
| US-20100105755-A1 | SUBSTITUTED BENZAMIDE MODULATORS OF DOPAMINE RECEPTOR | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105755-A1 | SUBSTITUTED BENZAMIDE MODULATORS OF DOPAMINE RECEPTOR | DBH, SLC6A3, HTR5A | FFAR3 267/4885DPP4 708/4885INMT 501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.